Home > Insider Trading > Filing (0001477449-24-000041)

Filing Details

Accession Number:: 0001477449-24-000041
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-05 16:08:16
Reporting Period:: 2024-03-01

Accepted Time:: 2024-03-05 16:08:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	Services-Offices & Clinics Of Doctors Of Medicine (8011)	043705970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1726221	Andrew Turitz	C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577	Evp, Corporate Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-03-01	475	$15.06	25,193	No	4	S	Direct
Common Stock	Acquisiton	2024-03-01	4,226	$0.00	29,419	No	4	M	Direct
Common Stock	Acquisiton	2024-03-01	437	$0.00	29,856	No	4	M	Direct
Common Stock	Acquisiton	2024-03-01	867	$0.00	30,723	No	4	M	Direct
Common Stock	Acquisiton	2024-03-01	1,348	$0.00	32,071	No	4	M	Direct
Common Stock	Acquisiton	2024-03-01	12,400	$0.00	44,471	No	4	M	Direct
Common Stock	Acquisiton	2024-03-01	1,148	$0.00	45,619	No	4	M	Direct
Common Stock	Disposition	2024-03-04	6,190	$14.52	39,429	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Units	Acquisiton	2024-03-01	12,679	$0.00	12,679	$0.00
Common Stock	Performance Stock Units	Disposition	2024-03-01	4,226	$0.00	4,226	$0.00
Common Stock	Performance Stock Units	Disposition	2024-03-01	437	$0.00	437	$0.00
Common Stock	Performance Stock Units	Disposition	2024-03-01	867	$0.00	867	$0.00
Common Stock	Restricted Stock Units	Disposition	2024-03-01	1,348	$0.00	1,348	$0.00
Common Stock	Restricted Stock Units	Disposition	2024-03-01	12,400	$0.00	12,400	$0.00
Common Stock	Restricted Stock Units	Disposition	2024-03-01	1,148	$0.00	1,148	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,679	No	4	A	Direct
8,453	No	4	M	Direct
0	No	4	M	Direct
0	No	4	M	Direct
5,392	No	4	M	Direct
24,802	No	4	M	Direct
0	No	4	M	Direct

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 27, 2023.
Performance stock units convert to shares of TDOC common stock on a one-for-one basis
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.